T 0820/21 (Cytotoxicity-inducing therapeutic agent/CHUGAI SEIYAKU KABUSHIKI KAISHA) of 11.07.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T082021.20230711
- Date of decision
- 11 July 2023
- Case number
- T 0820/21
- Petition for review of
- -
- Application number
- 11845786.0
- IPC class
- C07K 16/28C12N 1/21C12N 15/09A61P 35/00A61K 39/395C07K 16/46C12N 1/19C12N 5/10C07K 16/30C12N 1/15
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Cytotoxicity-inducing therapeutic agent
- Applicant name
- Chugai Seiyaku Kabushiki Kaisha
- Opponent name
- (1) Janssen Biotech, Inc.
(2) Boehringer Ingelheim RCV GmbH & Co KG /Boehringer Ingelheim International GmbH
(3) James Poole Limited
(4) Mathys & Squire LLP
(5) Genmab A/S - Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Basis of decision - text or agreement to text withdrawn by patent proprietor
- Catchword
- -
- Citing cases
- T 1134/21
Order
For these reasons it is decided that:
The appeal is dismissed.